557 related articles for article (PubMed ID: 16517226)
1. Mass spectrometry for congenital disorders of glycosylation, CDG.
Wada Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):3-8. PubMed ID: 16517226
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry in the characterization of human genetic N-glycosylation defects.
Barone R; Sturiale L; Garozzo D
Mass Spectrom Rev; 2009; 28(3):517-42. PubMed ID: 18844296
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry in the detection and diagnosis of congenital disorders of glycosylation.
Wada Y
Eur J Mass Spectrom (Chichester); 2007; 13(1):101-3. PubMed ID: 17878547
[TBL] [Abstract][Full Text] [Related]
4. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis.
Faid V; Chirat F; Seta N; Foulquier F; Morelle W
Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of congenital disorders of glycosylation type-I using protein chip technology.
Mills K; Mills P; Jackson M; Worthington V; Beesley C; Mann A; Clayton P; Grunewald S; Keir G; Young L; Langridge J; Mian N; Winchester B
Proteomics; 2006 Apr; 6(7):2295-304. PubMed ID: 16552784
[TBL] [Abstract][Full Text] [Related]
6. Multiplexed glycoproteomic analysis of glycosylation disorders by sequential yolk immunoglobulins immunoseparation and MALDI-TOF MS.
Sturiale L; Barone R; Palmigiano A; Ndosimao CN; Briones P; Adamowicz M; Jaeken J; Garozzo D
Proteomics; 2008 Sep; 8(18):3822-32. PubMed ID: 18712764
[TBL] [Abstract][Full Text] [Related]
7. Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis.
Butler M; Quelhas D; Critchley AJ; Carchon H; Hebestreit HF; Hibbert RG; Vilarinho L; Teles E; Matthijs G; Schollen E; Argibay P; Harvey DJ; Dwek RA; Jaeken J; Rudd PM
Glycobiology; 2003 Sep; 13(9):601-22. PubMed ID: 12773475
[TBL] [Abstract][Full Text] [Related]
8. [Congenital disorders of glycosylation].
Durand G; Dupré T; Vuillaumier-Barrot S; Seta N
Ann Pharm Fr; 2003; 61(5):330-9. PubMed ID: 13130291
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik.
Grubenmann CE; Frank CG; Hülsmeier AJ; Schollen E; Matthijs G; Mayatepek E; Berger EG; Aebi M; Hennet T
Hum Mol Genet; 2004 Mar; 13(5):535-42. PubMed ID: 14709599
[TBL] [Abstract][Full Text] [Related]
10. Effect of glycosylation on the protein pattern in 2-D-gel electrophoresis.
Kleinert P; Kuster T; Arnold D; Jaeken J; Heizmann CW; Troxler H
Proteomics; 2007 Jan; 7(1):15-22. PubMed ID: 17152094
[TBL] [Abstract][Full Text] [Related]
11. Methods in enzymology: O-glycosylation of proteins.
Peter-Katalinić J
Methods Enzymol; 2005; 405():139-71. PubMed ID: 16413314
[TBL] [Abstract][Full Text] [Related]
12. Screening and diagnosis of congenital disorders of glycosylation.
Marklová E; Albahri Z
Clin Chim Acta; 2007 Oct; 385(1-2):6-20. PubMed ID: 17716641
[TBL] [Abstract][Full Text] [Related]
13. The underglycosylation of plasma alpha 1-antitrypsin in congenital disorders of glycosylation type I is not random.
Mills K; Mills PB; Clayton PT; Mian N; Johnson AW; Winchester BG
Glycobiology; 2003 Feb; 13(2):73-85. PubMed ID: 12626422
[TBL] [Abstract][Full Text] [Related]
14. Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups.
Wopereis S; Morava E; Grünewald S; Adamowicz M; Huijben KM; Lefeber DJ; Wevers RA
Glycobiology; 2005 Dec; 15(12):1312-9. PubMed ID: 16037491
[TBL] [Abstract][Full Text] [Related]
15. A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex formation.
Foulquier F; Ungar D; Reynders E; Zeevaert R; Mills P; García-Silva MT; Briones P; Winchester B; Morelle W; Krieger M; Annaert W; Matthijs G
Hum Mol Genet; 2007 Apr; 16(7):717-30. PubMed ID: 17220172
[TBL] [Abstract][Full Text] [Related]
16. Congenital disorders of N-glycosylation including diseases associated with O- as well as N-glycosylation defects.
Leroy JG
Pediatr Res; 2006 Dec; 60(6):643-56. PubMed ID: 17065563
[TBL] [Abstract][Full Text] [Related]
17. Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia.
Sturiale L; Barone R; Fiumara A; Perez M; Zaffanello M; Sorge G; Pavone L; Tortorelli S; O'Brien JF; Jaeken J; Garozzo D
Glycobiology; 2005 Dec; 15(12):1268-76. PubMed ID: 16037488
[TBL] [Abstract][Full Text] [Related]
18. Laboratory diagnosis of congenital disorders of glycosylation type I by analysis of transferrin glycoforms.
Babovic-Vuksanovic D; O'Brien JF
Mol Diagn Ther; 2007; 11(5):303-11. PubMed ID: 17963418
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical features in a Congolese infant with congenital disorder of glycosylation (CDG)-IIx.
Nsibu NC; Jaeken J; Carchon H; Mampunza M; Sturiale L; Garozzo D; Mashako MN; Tshibassu MP
Eur J Paediatr Neurol; 2008 May; 12(3):257-61. PubMed ID: 17884642
[TBL] [Abstract][Full Text] [Related]
20. Global and site-specific detection of human integrin alpha 5 beta 1 glycosylation using tandem mass spectrometry and the StrOligo algorithm.
Ethier M; Krokhin O; Ens W; Standing KG; Wilkins JA; Perreault H
Rapid Commun Mass Spectrom; 2005; 19(5):721-7. PubMed ID: 15702487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
